Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Jones
DSI
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Barranquilla, Atlántico, Colombia
- Facility name not stated
Bogota, Cundinamarca, Colombia
- Facility name not stated
Bucaramanga, Santander Department, Colombia
- Facility name not stated
Mumbai, Dadar, India
- Facility name not stated
Durgāpura, Jaipur, India
- Facility name not stated
Bangalore, Karnataka, India
- Facility name not stated
Kochi, Kerala, India
- Facility name not stated
Nashik, Maharashtra, India
- Facility name not stated
Las Palmas, Chihuahua, Mexico
- Facility name not stated
Delegacion, Cuauhtemoc, Mexico
- Facility name not stated
Guadalajara, Jalisco, Mexico
- Facility name not stated
Monterrey, Nuevo León, Mexico
- Facility name not stated
Hermosillo, Sonora, Mexico
- Facility name not stated
Mérida, Yucatán, Mexico
- Facility name not stated
Birmingham, Alabama, United States
- Facility name not stated
Los Gatos, California, United States
- Facility name not stated
Tarzana, California, United States
- Facility name not stated
Ocala, Florida, United States
- Facility name not stated
Pocatello, Idaho, United States
- Facility name not stated
Gary, Indiana, United States
- Facility name not stated
New Orleans, Louisiana, United States
- Facility name not stated
Olive Branch, Mississippi, United States
- Facility name not stated
Dundee, New York, United States
- Facility name not stated
West Seneca, New York, United States
- Facility name not stated
Statesville, North Carolina, United States
- Facility name not stated
Kent, Ohio, United States
- Facility name not stated
Marion, Ohio, United States
- Facility name not stated
Portland, Oregon, United States
- Facility name not stated
Corpus Christi, Texas, United States
- Facility name not stated
Dallas, Texas, United States
- Facility name not stated
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2007
- Primary completion
- 30 Apr 2009
- Completion
- 31 May 2009
- Last update posted
- 27 Jul 2010
- Registered enrollment
- 502
- Registry id
- NCT00570739
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.